MabVax Therapeutics Holdings, Inc. (MBVX)

Company Overview
Telik, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule drugs for the treatment of cancer and inflammatory diseases. Its lead product candidate TELCYTA is a small molecule cancer drug product designed to be activated in cancer cells. TELCYTA is in phase 3 clinical trials for the treatment of platinum resistant or refractory ovarian cancer and lung cancer. The company’s other product TELINTRA is a small molecule bone marrow stimulant that activates signaling pathways and lead to the growth and differentiation of blood cells. TELINTRA is in Phase-2 trials in patients with myelodysplastic syndrome, a preleukemic conditio...
read more

COMPANY INFO

To see the headquarters in Google Street View &trade, drag this yellow guy: over to the red pointer:

Contact Information:

Business Address: 700 Hansen Way, Palo Alto, CA 94304, United States
Mailing Address: -
Phone: 650-845-7700
Fax: 650-845-7800
Website: http//www.telik.com

Company Details:

Symbol: MBVX
SIC: 2834
State location: CA
Sector: -
State of Inc: DE
Employees: 41
Type: -

Key executives:

Name Age Position
Cynthia M. Butitta 62 Chief Operating Officer, Chief Financial Officer and Principal Accounting Officer
Marc L. Steuer 70 Sr. VP of Bus. Devel.
Michael M. Wick M.D., Ph.D. 71 Chairman, Chief Exec. Officer and Pres
Reinaldo F. Gomez Ph.D. 71 Sr. VP of Product Devel.
William P. Kaplan Esq. 63 VP, Sec. and Gen. Counsel